Related Experiment Videos
[Detection and long-term treatment of ventricular extrasystole in patients with ischemic heart disease]
Kardiologiia
|September 1, 1983
Insights
Beta-blocking agents significantly reduced sudden cardiac death and myocardial infarction in patients experiencing frequent ventricular extrasystoles. This study highlights the protective effects of these medications in high-risk cardiac patients.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Frequent and complicated ventricular extrasystoles (VEs) are a clinical concern.
- Bicycle ergometric testing and one-hour monitoring identified patients with these arrhythmias.
Purpose:
- To investigate the long-term effects of beta-blocking agents on patients with frequent ventricular extrasystoles.
- To assess the impact on outcomes such as sudden death and myocardial infarction.
Summary:
- A study involving 105 patients with frequent ventricular extrasystoles found that long-term treatment with beta-blocking agents led to a reduction in adverse cardiac events.
- The treated group showed a lower incidence of sudden death and recurrent myocardial infarction compared to the control group.
Impact:
- Beta-blocker therapy is effective in mitigating serious cardiovascular events in patients with significant ventricular arrhythmias.
- This research supports the use of beta-blockers for secondary prevention in patients at risk of sudden cardiac death.
Abstract:
One-hour monitoring and bicycle ergometric testing revealed frequent (more than 10 per hour) and complicated ventricular extrasystoles in 105 patients. They were distributed between the treatment and control groups. Long-term treatment with beta-blocking agents reduced the frequency of sudden death and repeated myocardial infarction in the treated group as compared to the controls.